6th Feb 2007 16:46
Allergy Therapeutics PLC06 February 2007 Allergy Therapeutics plc Holding in Company Allergy Therapeutics plc (the "Company") received notification on 2 February2007 from AXA Investment Managers UK Ltd that AXA S.A. and its group companiesare interested in 5,779,620 ordinary shares of 0.1 pence each ("Ordinary Shares"), comprising a beneficial interest of 2,400,000 Ordinary Shares and anon-beneficial interest of 3,379,620 Ordinary Shares, representing 7.05 percent. of the Company's issued share capital of 81,950,632 Ordinary Shares, asdetailed below: Company / Fund Holding %AXA Framlington Xerox Final Salary Pension Scheme 447,250 0.55 (Non-beneficial)AXA Framlington Islington Group Pension Scheme 280,832 0.34 (Non-beneficial)AXA Framlington SEI UK Equity 500,000 0.61 (Non-beneficial)AXA Framlington Throgmorton Trust 2,400,000 2.93 (Beneficial)AXA Framlington UK Smaller Companies 1,400,000 1.71 (Non-beneficial)AXA Framlington Biotech 283,200 0.35 (Non-beneficial)AXA Framlington BAE Systems Pensions Fund CIF Trustees 325,644 0.40 (Non-beneficial)AXA Framlington BAE Systems 2000 Pensions Fund 142,694 0.17 (Non-beneficial) Total 5,779,620 7.05% This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares: